The progressive decrease in hepatic Ceacam1 mRNA stems from a compromised ability of insulin to induce Ceacam1 transcription under conditions of hyperphagia-driven insulin resistance [2,3] and from PPARα activation by lipolysis-derived fatty acids [3]. The gene discussed is CEACAM1; the disease is Insulin resistance.